Omer Kucuk, MD, has joined Emory University’s Winship Cancer Institute in Atlanta as professor of hematology and medical oncology. Dr. Kucuk conducted the earliest clinical trials on soy and lycopene supplements in prostate cancer treatment. He was previously at the Karmanos Cancer Center at Wayne State University in Detroit.
Two new appointments have been made at New York’s Memorial-Sloan Kettering Cancer Center (MSKCC). Marcel R. M. van den Brink, MD, PhD, has been named head of the division of hematologic oncology. Dr. van den Brink also will lead a laboratory in the MSKCC immunology program. Jason Lewis, PhD, has been named chief of radiochemistry service in the department of radiology and director of the Cyclotron- Radiochemistry Core facility. Dr. Lewis comes to MSKCC from Washington University School of Medicine in St. Louis.
Victor E. Reuter, MD, vice chair of the department of pathology and co-director of MSKCC Pathology Core Facility, has assumed the presidency of the United States and Canadian Academy of Pathology (USCAP). Also at MSKCC, Neal Rosen, MD, PhD, Enid A. Haupt chair in medical oncology, garnered a $1 million, three-year team science award from the Melanoma Research Alliance for his work on the therapeutic inhibition of mutant-activated signaling pathways.
Lucile L. Adams-Campbell, PhD, has been named associate director for Minority Health and Health Disparities Research at Lombardi Comprehensive Cancer Center, Georgetown University Medical Center. Dr. Adams-Campbell, who comes to Washington DC, from Howard University Cancer Center in Atlanta, will focus primarily on community outreach and community- based participatory research. Also at Lombardi, John L. Marshall, MD, chief of hematology/ oncology, has been elected president of the International Society of Gastrointestinal Oncology (ISGIO). Dr. Marshall will serve a one-year term.
The National Cancer Institute has awarded a Specialized Programs of Research Excellence (SPORE) grant in lung cancer to Gerold Bepler, MD, PhD, and his team at H. Lee Moffitt Cancer Center & Research Institute in Tampa, Fla. Dr. Bepler is the program leader for thoracic oncology at Moffi tt. The grant totals about $10.5 million over fi ve years.
Audrey Evans, MD, has been named the 2008 honorary member of ASTRO. Dr. Evans is a pediatric and radiation oncologist based at New York’s Beth Israel Medical Center. She developed the Evans Staging System for neuroblastoma.
M. Steven Piver, MD, has been appointed chair of the New York State Ovarian Cancer Information Advisory Council. Dr. Piver is a senior consultant in gynecologic oncology at the Specialty Center for Women in Buffalo, New York. In addition, Eva Chalas, MD, and Mark Bennett Pochapin, MD, have joined the council. Dr. Chalas is with Long Island Gynecologic Oncologists in Smithtown, New York. Dr. Pochapin is based at New York Presbyterian Hospital-Weill Cornell Medical Center.
Leonard A. Zwelling, MD, MBA, a professor of medicine and pharmacology at Houston’s M. D. Anderson Cancer Center, has been given a one-year fellowship in health policy by the Robert Wood Johnson Foundation.
Virologist Harald zur Hausen, MD, has received the 2008 Nobel Prize in Physiology or Medicine for his research on the human papillomavirus (HPV). Dr. zur Hausen is the former scientifi c director of the German Cancer Research Centre in Heidelberg.
The French Association for Cancer Research has bestowed the ARC Leopold Griffuel Prize on Carlo Croce, MD. Dr. Croce is director of human cancer genetics at Ohio State University in Columbus. He is also chair of the department of molecular virology, immunology, and medical genetics at Ohio State College of Medicine.
Nidal Mahgoub, MD, has joined the department of oncology at the American Hospital in Dubai. Specializing in leukemia, Dr. Mahgoub was previously based in the department of pediatric hematology/oncology at Kaiser-Permanente Medical Group in Santa Clara, Calif.